Esomeprazole based triple therapy regimens (EAC/EAM) on H.pylori eradication therapy showed high success rate even if on EM of CYP2C19 polymorphism or CAM resistance.
Conference
UEG Week 2016
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing